JREB:F:F-JPMorgan ETFs (Ireland) ICAV - EUR Corporate Bond Research Enhanced Index UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 103.34

Change

+0.21 (+0.20)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.28 (-1.06%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.35 (-0.70%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.28 (-0.51%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 53.24B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.23 (+0.24%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.09B
0ZC:F Zscaler Inc

+0.42 (+0.28%)

USD 37.92B

ETFs Containing JREB:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.74% 40% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.74% 36% F 47% F
Trailing 12 Months  
Capital Gain 8.91% 50% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.91% 46% F 53% F
Trailing 5 Years  
Capital Gain -2.52% 29% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.52% 29% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain -1.13% 32% F 42% F
Dividend Return -1.13% 30% F 37% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.66% 80% B- 95% A
Risk Adjusted Return -16.96% 30% F 33% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.